Immune perturbation by the ileal microbiota in multiple sclerosis.
Jensen LT. and Fugger L., (2025), Proc Natl Acad Sci U S A, 122
A repair pathway lost in multiple sclerosis provides a new drug opportunity.
Jensen LT. et al, (2024), Nat Immunol, 25, 385 - 386
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
Lippert AH. et al, (2024), Immunity
Ancient DNA reveals evolutionary origins of autoimmune diseases.
Barrie W. et al, (2024), Nat Rev Immunol
Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.
Barrie W. et al, (2024), Nature, 625, 321 - 328
The selection landscape and genetic legacy of ancient Eurasians.
Irving-Pease EK. et al, (2024), Nature, 625, 312 - 320
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.
Jensen LT. et al, (2023), EBioMedicine, 97
Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade
KAUR G. et al, (2022), Nature Communications
Identification of early neurodegenerative pathways in progressive multiple sclerosis.
Kaufmann M. et al, (2022), Nat Neurosci
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19.
Francis A. et al, (2022), Lancet Neurol, 21, 217 - 218
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
Huang J. et al, (2020), Proc Natl Acad Sci U S A
A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.
Faergeman SL. et al, (2020), Cell Death Dis, 11
Identifying cross-disease components of genetic risk across hospital data in the UK Biobank.
Cortes A. et al, (2020), Nat Genet, 52, 126 - 134
B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
du Pré MF. et al, (2019), The Journal of experimental medicine
A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.
Ooi JD. et al, (2019), Nat Commun, 10
Immunomodulation in multiple sclerosis: promises and pitfalls.
Dendrou CA. and Fugger L., (2017), Curr Opin Immunol, 49, 37 - 43